Atul Dev
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 6
-
- Nanoplatforms for cancer theranostics 4
- Advanced Chemical Sensor Technologies 2
- Co-authors
- Surajit Karmakar (23 shared papers)Anup Kumar Srivastava (2 shared papers)Ankur Sood (8 shared papers)Subhasree Roy Choudhury (15 shared papers)Anup Kumar Srivastava (9 shared papers)Anuj Kumar (4 shared papers)Sung Soo Han (4 shared papers)Mohammed Nadim Sardoiwala (8 shared papers)
- Journals
- Materials Science and Engineering C (2 papers)ACS Applied Nano Materials (2 papers)Environmental Chemistry Letters (2 papers)Carbohydrate Polymers (1 paper)ACS Biomaterials Science & Engineering (1 paper)
- Partner nations
- IndiaUnited StatesSouth Korea
In The Last Decade
Atul Dev
30 papers receiving 1.6k citations
Atul Dev's Hit Papers
Peers
Comparison fields: 5 of 134
- Hepatology 263
- Biomaterials 246
- Molecular Medicine 91
- Pharmaceutical Science 71
- Rehabilitation 71
Countries citing papers authored by Atul Dev
This map shows the geographic impact of Atul Dev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Dev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Dev more than expected).
Fields of papers citing papers by Atul Dev
This network shows the impact of papers produced by Atul Dev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Dev. The network helps show where Atul Dev may publish in the future.
Co-authors
The 25 scholars most cited alongside Atul Dev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study Hit paper breakdown → | 2020 | 469 |
| 2 | 2017 | 257 | |
| 3 | 2022 | 185 | |
| 4 | 2020 | 97 | |
| 5 | 2023 | 89 | |
| 6 | 2017 | 88 | |
| 7 | 2017 | 64 | |
| 8 | 2020 | 48 | |
| 9 | 2020 | 39 | |
| 10 | 2019 | 38 | |
| 11 | 2021 | 36 | |
| 12 | 2017 | 31 | |
| 13 | 2021 | 28 | |
| 14 | 2024 | 25 | |
| 15 | 2022 | 24 | |
| 16 | 2016 | 18 | |
| 17 | 2020 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2023 | 12 | |
| 20 | 2018 | 11 |
About Atul Dev
Atul Dev is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Cancer Research and Neurology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (4 papers), Neuroblastoma Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Nanoparticles: synthesis and applications (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Advanced Chemical Sensor Technologies (2 papers) and Photodynamic Therapy Research Studies (2 papers). The work is most often cited by research in Hepatology (263 citations), Biomaterials (246 citations), Molecular Medicine (91 citations), Pharmaceutical Science (71 citations) and Rehabilitation (71 citations). Atul Dev has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Surajit Karmakar, Anup Kumar Srivastava, Ankur Sood, Subhasree Roy Choudhury, Anup Kumar Srivastava, Anuj Kumar, Sung Soo Han, Mohammed Nadim Sardoiwala, Soni Jignesh Mohanbhai and Nadine Millot. Their work appears in journals such as Materials Science and Engineering C, ACS Applied Nano Materials, Environmental Chemistry Letters, Carbohydrate Polymers and ACS Biomaterials Science & Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.